These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8348647)

  • 1. [Personal experience with immunosuppressive therapy of endogenous uveitis].
    Ríhová E; Boguszaková J; Michalová K; Havlíková M; Poch T
    Cesk Oftalmol; 1993 Jun; 49(3):139-44. PubMed ID: 8348647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial experience with therapy of endogenous uveitis with Consupren--the Czech cyclosporin A].
    Ríhová E; Poch T; Boguszaková J; Havlíková M; Michalová K
    Cesk Oftalmol; 1994 Oct; 50(5):302-9. PubMed ID: 7805119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications and complications of systemic corticosteroid therapy in treatment of uveitis].
    Auer C; Tran VT; Guex-Crosier Y; Pittet N; Herbort CP
    Klin Monbl Augenheilkd; 1994 May; 204(5):337-9. PubMed ID: 8051866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous uveitis. Retrospective clinical study].
    Todea V; Rusu M
    Oftalmologia; 1997; 41(2):48-51. PubMed ID: 15328642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide therapy of peripheral uveitis.
    Buckley CE; Gills JP
    Arch Intern Med; 1969 Jul; 124(1):29-35. PubMed ID: 5791483
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the treatment of autoimmune uveitis with prednisone and with cyclophosphamide and azathioprine].
    Flores M; Gudiño Pérez R; Ríos Prado R; Almedia Arvizu VM; Castrejón Vázquez MI; Ocampo AA
    Rev Alerg Mex; 2001; 48(3):75-9. PubMed ID: 11554127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe refractory uveitis with intravenous cyclophosphamide.
    Rosenbaum JT
    J Rheumatol; 1994 Jan; 21(1):123-5. PubMed ID: 8151566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of Henoch-Schönlein disease with intensive immunosuppressive treatment.
    Faedda R; Pirisi M; Satta A; Bosincu L; Bartoli E
    Clin Pharmacol Ther; 1996 Nov; 60(5):576-81. PubMed ID: 8941031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endogenous uveitis].
    Ríhová E; Havlíková M; Michalová K; Boguszaková J; Stara J; Poch T
    Cesk Oftalmol; 1994 Apr; 50 Suppl():S32-40. PubMed ID: 8194118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute, idiopathic, bilateral uveitis with periphlebitis--case report].
    Nowosielska A; Czarnecki W; Brydak-Godowska J; Dróbecka-Brydak E; Nowacka E; Lao M; Durlik M
    Klin Oczna; 2005; 107(4-6):372-5. PubMed ID: 16118962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclophosphamide in the treatment of immune hemocytopenias].
    Sakalová A; Hrubisko M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):559-64. PubMed ID: 54306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.